CYP17 and breast cancer: no overall effect, but what about interactions? (Q25257341)

6 July 2017

title

CYP17 and breast cancer: no overall effect, but what about interactions? (English)

1 reference

6 July 2017

2

Jacques Simard

1 reference

6 July 2017

1

Julian Little

1 reference

6 July 2017

language of work or name

English

0 references

publication date

20 September 2005

1 reference

6 July 2017

published in

Breast Cancer Research

1 reference

6 July 2017

volume

7

1 reference

6 July 2017

issue

6

1 reference

6 July 2017

page(s)

238-242

1 reference

CYP17 gene polymorphism in relation to breast cancer risk: a case-control study

6 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410734

CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410734

CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410734

CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410734

CYP17 genotype and breast cancer risk

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410734

A comprehensive review of genetic association studies

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410734

Molecular biology of the 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family

7 April 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410734

Characterization of single-nucleotide polymorphisms in coding regions of human genes

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410734

Assessing the probability that a positive report is false: an approach for molecular epidemiology studies

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410734

Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410734

Replication validity of genetic association studies

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410734

A network of investigator networks in human genome epidemiology

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410734

Overview of dehydroepiandrosterone biosynthesis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410734

CYP17 gene polymorphisms: prevalence and associations with hormone levels and related factors. a HuGE review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410734

The future of association studies: gene-based analysis and replication

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410734

Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410734

CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 status

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410734

Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410734

Commentary: meta-analysis of individual participants' data in genetic epidemiology

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410734

NF-1C, Sp1, and Sp3 are essential for transcription of the human gene for P450c17 (steroid 17alpha-hydroxylase/17,20 lyase) in human adrenal NCI-H295A cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410734

Steroid metabolism gene CYP17 polymorphism and the development of breast cancer.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410734

A polymorphism in the CYP17 gene is associated with male breast cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410734

No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410734

Methods for pooled analyses of epidemiologic studies.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410734

Physiological Changes in Dehydroepiandrosterone Are Not Reflected by Serum Levels of Active Androgens and Estrogens But of Their Metabolites: Intracrinology

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410734

Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women

31 May 2018

1 reference

Polymorphisms associated with circulating sex hormone levels in postmenopausal women

21 January 2018

1 reference

Association between CYP17 gene polymorphism and risk of breast cancer in young women.

21 January 2018

1 reference

No association of the 5' promoter region polymorphism of CYP17 with breast cancer risk in Japan.

21 January 2018

1 reference

CYP17 and SULT1A1 gene polymorphisms in Indian breast cancer

21 January 2018

1 reference

HSD17B1 and CYP17 polymorphisms and breast cancer risk among Chinese women in Singapore

21 January 2018

1 reference

CYP17 polymorphism in the groups of distinct breast cancer susceptibility: comparison of patients with the bilateral disease vs. monolateral breast cancer patients vs. middle-aged female controls vs. elderly tumor-free women.

21 January 2018

1 reference

Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case-control study

21 January 2018

1 reference

Betting odds and genetic associations.

21 January 2018

1 reference

Does haplotype diversity predict power for association mapping of disease susceptibility?

21 January 2018

1 reference

The Reliable Identification of Disease-Gene Associations

21 January 2018

1 reference

Familial Risks, Early-Onset Breast Cancer, and BRCA1 and BRCA2 Germline Mutations

21 January 2018

1 reference

No association of polymorphisms in CYP17, CYP19, and HSD17-B1 with plasma estradiol concentrations in 1,090 British women

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410734

Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidates.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410734

A polymorphism in the CYP17 gene increases the risk of breast cancer

28 November 2018

1 reference

12 December 2020

Association between CYP17 polymorphisms and the development of breast cancer

1 reference

12 December 2020

The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer

1 reference

12 December 2020

CYP17 and breast cancer risk: the polymorphism in the 5' flanking area of the gene does not influence binding to Sp-1

1 reference

12 December 2020

Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility

1 reference

12 December 2020

Genetic polymorphism in CYP17 and breast cancer risk in Japanese women

1 reference

12 December 2020

The risk of breast cancer associated with dietary lignans differs by CYP17 genotype in women

1 reference

12 December 2020

The human genome project is complete. How do we develop a handle for the pump?

1 reference

12 December 2020

CYP17 promoter polymorphism and breast cancer in Australian women under age forty years

1 reference

12 December 2020

Identifiers

DOI

10.1186/BCR1320

1 reference

Dimensions Publication ID

6 July 2017

0 references

1 reference

6 July 2017

1 reference